In the present study, we utilized ProPPr with the AT8 monoclonal antibody (phospho-tau pS202/pT205) as a specific probe for the unbiased profiling of associated proteomes across the 4 major tauopathies (AD, CBD, PiD and PSP). Here, MAPT is linked to Alzheimer disease.